• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Published: May 2014
  • Region: Global
  • 103 Pages
  • Transparency Market Research

"Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019"

A surge in the number of cancer and cardiovascular patients globally has prompted the growth of the medical imaging reagents market. Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems.

The medical imaging reagents market has been primarily segmented by class, technology and applications. On the basis of product class, the medical imaging reagents market comprises contrast reagents, optical reagents and nuclear reagents. READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Medical Imaging Reagents Market

Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing number of elderly population expected to drive market growth
3.2.1.2 Increasing prevalence rate of cancer, cardiovascular and neurological diseases expected to trigger market growth
3.2.1.3 Escalating demand for diagnostic imaging procedures influences imaging reagents sales
3.2.1.4 Technological development likely to spur the growth of the imaging reagents market
3.2.2 Market Restraints
3.2.2.1 Shortage of supplies of imaging reagents impede the growth of the market
3.2.2.2 Stringent regulatory approvals likely to hamper the market growth
3.2.2.3 Reluctance in adopting nuclear products restrict the market growth
3.2.3 Market Opportunities
3.2.3.1 Strengthening distribution network in emerging markets
3.2.3.2 Development of nuclear products based personalized therapy
3.3 Porter's Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
3.5 Market Share Analysis for Global Medical Imaging Reagents, by Key Players, 2012 (Value %)

Chapter 4 Global Medical Imaging Reagents Market, by Class
4.1 Overview
4.1.1 Global Medical Imaging Reagents Market Revenue, by Class, 2011 – 2019 (USD Million)
4.2 Contrast Reagents
4.2.1 Global Contrast Reagents Market Revenue, 2011 – 2019 (USD Million)
4.3 Optical Reagents
4.3.1 Global Optical Reagents Market Revenue, 2011 – 2019 (USD Million)
4.4 Nuclear Reagents
4.4.1 Global Nuclear Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Medical Imaging Reagents Market, by Technology
5.1 Overview
5.1.1 Global Medical Imaging Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million)
5.2 Nanoparticles
5.2.1 Global Nanoparticles Market Revenue, 2011 – 2019 (USD Million)
5.3 Fluorescent Proteins
5.3.1 Global Fluorescent Proteins Market Revenue, 2011 – 2019 (USD Million)
5.4 Fluorescent Dyes and Probes
5.4.1 Global Fluorescent Dyes and Probes Market Revenue, 2011 – 2019 (USD Million)
5.5 Radiopharmaceuticals
5.5.1 Global Radiopharmaceuticals Market Revenue, 2011 – 2019 (USD Million)
5.6 Quantum Dots
5.6.1 Global Quantum Dots Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Medical Imaging Reagents Market, by Application
6.1 Overview
6.1.1 Global Medical Imaging Reagents Market Revenue, by Application, 2011 – 2019 (USD Million)
6.2 Diagnostics
6.2.1 Global Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.3 Drug Discovery and Development
6.3.1 Global Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
6.4 Research and Development
6.4.1 Global Research and Development Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Global Medical Imaging Reagents Market, by Geography
7.1 Overview
7.1.1 Global Medical Imaging Reagents Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.4 Asia Pacific
7.4.1 Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 8 Recommendations
8.1 Market Strategy for Success
8.2 Barriers to be Considered

Chapter 9 Company Profiles
9.1 Bayer Healthcare AG
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Beckman Coulter, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Becton Dickinson & Company
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 Bracco Imaging SpA
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Cardinal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Lantheus Medical Imaging, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Promega Corporation
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Siemens Healthcare
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Thermo Fisher Scientific, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments

List of Figures

FIG. 1 Medical Imaging Reagents Market Segmentation
FIG. 2 Global Medical Imaging Reagents Market, by Class, 2012 (USD Million)
FIG. 3 Global Medical Imaging Reagents Market, by Technology, 2012 (USD Million)
FIG. 4 Global Medical Imaging Reagents Market, by Application, 2012 (USD Million)
FIG. 5 Comparative Analysis: Global Medical Imaging Reagents Market, by Geography, 2012 & 2019 (Value %)
FIG. 6 Global Medical Imaging Reagents Market: Drivers and Restraints
FIG. 7 Porter's Five Forces Analysis: Global Medical Imaging Reagents Market
FIG. 8 Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
FIG. 9 Market Share Analysis: Global Medical Imaging Reagents Market, by Key
Players, 2012 (Value %)
FIG. 10 Global Contrast Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Optical Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Nuclear Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Nanoparticles Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Fluorescent Proteins Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Fluorescent Dyes and Probes Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Radiopharmaceuticals Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Quantum Dots Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Research and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 North America Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Europe Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 RoW Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Bayer Healthcare AG, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Becton, Dickinson and Company, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Cardinal Health, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 28 Lantheus Medical Imaging, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Mallinckrodt Pharmaceuticals, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 30 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Thermo Fisher Scientific, Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Medical Imaging Reagents Market
TABLE 2 Global Medical Imaging Reagents Market Revenue, by Class, 2011 – 2019 (USD Million)
TABLE 3 Global Medical Imaging Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 4 Global Medical Imaging Reagents Market Revenue, by Application, 2011 – 2019 (USD Million)
TABLE 5 Global Medical Imaging Reagents Market Revenue, by Geography, 2011 – 2019 (USD Million)

Medical imaging reagents play an important role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. Medical imaging reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are chemicals that are specially designed to enhance images produced through imaging systems. Ongoing advances in proteomics, genomics and cellular analysis are supported by sophisticated imaging technologies including nanoparticles, radiopharmaceuticals, fluorescent proteins, quantum dots and fluorescent dyes and probes. Development in technologies such as polymerase chain reaction (PCR), biochips, hybrid imaging modalities and DNA sequencing relies on sensitive medical imaging reagents for producing enhanced images with detailed information.

The primary factors driving the growth of the medical imaging reagents market are increasing demand for diagnostic and functional imaging technologies. Moreover, other factors contributing to the growth of this market are escalating incidence rate of cardiac disorders and cancer. Furthermore, immense application scope of advance medical imaging reagents and patient safety are also some of the factors driving the growth of the medical imaging reagents market. However, some of the important factors that negatively affect the growth of this market are shortage in supplies; high development cost coupled with unfavorable reimbursement policies and low awareness rate among the patient population.

The medical imaging reagents market is categorized on the basis of class, technology and applications. The three main classes of imaging reagents are contrast reagents, optical reagents and nuclear reagents. The contrast reagents market of the medical imaging reagents accounted for the largest market in 2011 (44%). However, the nuclear reagents market is expected to experience the fastest growth rate during the forecast period owing to the high adoption rate for localized tracers and nuclear medicine. Moreover, the technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. Among these, nanoparticles technology is expected to grow at a high growth rate of over 8% from 2013 to 2019 due to the widespread applicability of these technologies along with high research and development initiatives being taken up for the development of their application areas. Furthermore, in terms of applications, this market is categorized into diagnostics, drug discovery and development as well as research and development; among which, drug discovery and development is expected to witness the highest growth during the forecast period. This growth can be attributed to the growing adoption rate of medical imaging reagents in the pre-clinical studies and medical interventions. However, diagnostic applications accounted for the largest market in terms of revenue due to the escalating patient base of chronic diseases (e.g. cancer, cardiovascular and neurological diseases).

North America is the largest market for medical imaging reagents owing to the increased incidence of cancer, cardiovascular and neurological diseases as well as high awareness about advanced imaging modalities and reagents, followed by Europe. However, rise in healthcare expenditure and the prevailing unstable economic conditions have led to a sluggish growth in the global medical imaging reagents market. Asia-Pacific is expected to foresee the highest growth due to strong economic developments, high incidence rate of cardiovascular diseases coupled with increasing demand for non-ionizing imaging reagents.

Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, Cardinal Health, Inc., GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc. are major companies leading the medical imaging reagents market.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos